Association between CYP2D6 and CYP2C19 genotypes and venlafaxine treatment failure: a retrospective study on two cohorts from Norway and the UK.

Yoomi Park; Hasan Çağın Lenk; Yitian Zhou; Volker M Lauschke; Espen Molden

doi:10.1016/s2215-0366(26)00238-5

SCHEDA SCIENTIFICA2026Studio osservazionale

Association between CYP2D6 and CYP2C19 genotypes and venlafaxine treatment failure: a retrospective study on two cohorts from Norway and the UK.

Yoomi Park, Hasan Çağın Lenk, Yitian Zhou, Volker M Lauschke, Espen Molden

The lancet. Psychiatry · 2026

Psicoterapia Psicopatologia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansVenlafaxine HydrochlorideCytochrome P-450 CYP2C19Retrospective StudiesTreatment FailureFemaleNorwayUnited KingdomCytochrome P-450 CYP2D6MaleGenotypeMiddle AgedMajor Depressive DisorderAgedAdult

Come citare questo studio

Yoomi Park, Hasan Çağın Lenk, Yitian Zhou, Volker M Lauschke, Espen Molden. (2026). Association between CYP2D6 and CYP2C19 genotypes and venlafaxine treatment failure: a retrospective study on two cohorts from Norway and the UK.. The lancet. Psychiatry. DOI: 10.1016/s2215-0366(26)00238-5

Consulta la pubblicazione originale ↗